VolitionRX (VNRX) Stock Statistics & Valuation Metrics

VolitionRX has a market cap or net worth of $16.66M. The enterprise value is $9.34M.

VolitionRX has 8,330,270 shares outstanding. The number of shares has decreased by -2.65% in one year.

VolitionRX’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 1236.74%.

The current PE Ratio of VolitionRX is ―. VolitionRX’s PEG ratio is 0.04.

In the last 12 months, VolitionRX had revenue of 1.73M and earned -23.36M in profits. Earnings per share was -4.40.

In the last 12 months, operating cash flow was -19.53M and capital expenditures -88.38K, giving a free cash flow of -19.61M billion.

VolitionRX pays an annual dividend of ―, resulting in a dividend yield of ―

VolitionRX upcoming earnings date is Aug 13, 2026, After Close (Confirmed).

VolitionRX as a current ratio of 0.17, with Debt / Equity ratio of ―

In the past 12 months, VolitionRX has paid 0.00 in taxes.

VolitionRX EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -1.90.

VolitionRX has $1.12M in cash and marketable securities with $1.75M in debt, giving a net cash position of -$10.35M billion.

Gross margin is ―, with operating margin of -1228.57%, and net profit margin of -1352.16%.

The average price target for VolitionRX is $40.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy